These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741 [TBL] [Abstract][Full Text] [Related]
4. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425 [TBL] [Abstract][Full Text] [Related]
5. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid. Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067 [TBL] [Abstract][Full Text] [Related]
7. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Fusshoeller A; Plail M; Grabensee B; Plum J Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322 [TBL] [Abstract][Full Text] [Related]
8. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Mortier S; Faict D; Lameire NH; De Vriese AS Kidney Int; 2005 Apr; 67(4):1559-65. PubMed ID: 15780112 [TBL] [Abstract][Full Text] [Related]
9. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]. Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F; BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574 [TBL] [Abstract][Full Text] [Related]
10. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane. Mortier S; Faict D; Gericke M; Lameire N; De Vriese A Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808 [TBL] [Abstract][Full Text] [Related]
11. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children. Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761 [TBL] [Abstract][Full Text] [Related]
12. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. Mortier S; De Vriese AS; McLoughlin RM; Topley N; Schaub TP; Passlick-Deetjen J; Lameire NH J Am Soc Nephrol; 2003 May; 14(5):1296-306. PubMed ID: 12707398 [TBL] [Abstract][Full Text] [Related]
13. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo. Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293 [TBL] [Abstract][Full Text] [Related]
14. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. Hekking LHP; Zareie M; Driesprong BAJ; Faict D; Welten AGA; de Greeuw I; Schadee-Eestermans IL; Havenith CEG; van den Born J; Ter Wee PM; Beelen RHJ J Am Soc Nephrol; 2001 Dec; 12(12):2775-2786. PubMed ID: 11729248 [TBL] [Abstract][Full Text] [Related]
15. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats. Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549 [TBL] [Abstract][Full Text] [Related]
16. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742 [TBL] [Abstract][Full Text] [Related]
17. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial. Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100 [TBL] [Abstract][Full Text] [Related]
18. In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function. Fischer FP; Schenk U; Kiefer T; Hübel E; Thomas S; Yatzidis H; Mettang T; Kuhlmann U Am J Kidney Dis; 1995 Dec; 26(6):924-33. PubMed ID: 7503067 [TBL] [Abstract][Full Text] [Related]
19. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid. Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882 [TBL] [Abstract][Full Text] [Related]
20. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity. Plum J; Schoenicke G; Grabensee B Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]